Celldex Therapeutics Statistics
Total Valuation
CLDX has a market cap or net worth of $1.38 billion. The enterprise value is $712.47 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CLDX has 66.39 million shares outstanding. The number of shares has increased by 29.03% in one year.
| Current Share Class | 66.39M |
| Shares Outstanding | 66.39M |
| Shares Change (YoY) | +29.03% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 98.05% |
| Float | 56.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 182.54 |
| Forward PS | 361.02 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 94.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.67, with a Debt / Equity ratio of 0.00.
| Current Ratio | 21.67 |
| Quick Ratio | 21.06 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.20% and return on invested capital (ROIC) is -17.55%.
| Return on Equity (ROE) | -23.20% |
| Return on Assets (ROA) | -16.88% |
| Return on Invested Capital (ROIC) | -17.55% |
| Return on Capital Employed (ROCE) | -30.70% |
| Revenue Per Employee | $40,640 |
| Profits Per Employee | -$961,565 |
| Employee Count | 186 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.36% in the last 52 weeks. The beta is 1.14, so CLDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -40.36% |
| 50-Day Moving Average | 19.56 |
| 200-Day Moving Average | 24.96 |
| Relative Strength Index (RSI) | 54.32 |
| Average Volume (20 Days) | 1,231,024 |
Short Selling Information
The latest short interest is 8.37 million, so 12.61% of the outstanding shares have been sold short.
| Short Interest | 8.37M |
| Short Previous Month | 9.13M |
| Short % of Shares Out | 12.61% |
| Short % of Float | 14.85% |
| Short Ratio (days to cover) | 9.24 |
Income Statement
In the last 12 months, CLDX had revenue of $7.56 million and -$178.85 million in losses. Loss per share was -$2.70.
| Revenue | 7.56M |
| Gross Profit | -176.94M |
| Operating Income | -217.21M |
| Pretax Income | -150.22M |
| Net Income | -178.85M |
| EBITDA | -213.94M |
| EBIT | -217.21M |
| Loss Per Share | -$2.70 |
Full Income StatementBalance Sheet
The company has $673.29 million in cash and $3.43 million in debt, giving a net cash position of $669.86 million or $10.09 per share.
| Cash & Cash Equivalents | 673.29M |
| Total Debt | 3.43M |
| Net Cash | 669.86M |
| Net Cash Per Share | $10.09 |
| Equity (Book Value) | 702.98M |
| Book Value Per Share | 10.59 |
| Working Capital | 661.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$171.51 million and capital expenditures -$1.84 million, giving a free cash flow of -$173.35 million.
| Operating Cash Flow | -171.51M |
| Capital Expenditures | -1.84M |
| Free Cash Flow | -173.35M |
| FCF Per Share | -$2.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,873.52% |
| Pretax Margin | -2,366.07% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.03% |
| Shareholder Yield | -29.03% |
| Earnings Yield | -12.94% |
| FCF Yield | -12.54% |
Dividend DetailsAnalyst Forecast
The average price target for CLDX is $50.00, which is 140.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.00 |
| Price Target Difference | 140.15% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 149.42% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666:1.
| Last Split Date | Feb 11, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.0666666:1 |
Scores
CLDX has an Altman Z-Score of 31.21 and a Piotroski F-Score of 1.
| Altman Z-Score | 31.21 |
| Piotroski F-Score | 1 |